Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BAMRASNARADURA INFECTIOUS DISEASES INSTITUTE

🇹🇭Thailand

Country: 🇹🇭Thailand

Ownership: -

Established: 1958-01-01

Employees: -

Market Cap: -

Website: http://bamras.ddc.moph.go.th/th/

Clinical Trials

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure

Phase 4

Completed

Conditions: HIV
AIDS
Lopinavir
Treatment Failure

Interventions: Drug: Ritonavir-boosted lopinavir
Drug: optimized background regimens (OBRs)

First Posted Date: 2010-08-27

Last Posted Date: 2013-05-13

Lead Sponsor: Bamrasnaradura Infectious Diseases Institute

Target Recruit Count: 63

Registration Number: NCT01189695

Locations: 🇹🇭
Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand

Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity

Completed

Conditions: Treatment Failure, HIV or AIDS
CD4 Cell Counts

Interventions: Drug: Efavirenz-based regimens

First Posted Date: 2010-01-08

Last Posted Date: 2011-03-15

Lead Sponsor: Bamrasnaradura Infectious Diseases Institute

Target Recruit Count: 559

Registration Number: NCT01044810

Locations: 🇹🇭
Bamrasnaradura Infectious Disease Institute, Nonthaburi, Thailand

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Phase 4

Terminated

Conditions: Tuberculosis
HIV Infections

Interventions: Drug: tenofovir, lamivudine, efavirenz

First Posted Date: 2009-11-17

Last Posted Date: 2011-11-17

Lead Sponsor: Bamrasnaradura Infectious Diseases Institute

Target Recruit Count: 156

Registration Number: NCT01014481

Locations: 🇹🇭
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand

Ritonavir-boosted Lopinavir Monotherapy

Phase 3

Completed

Conditions: HIV

Interventions: Drug: lopinavir/ritonavir soft gel capsule

First Posted Date: 2009-10-28

Last Posted Date: 2011-11-11

Lead Sponsor: Bamrasnaradura Infectious Diseases Institute

Target Recruit Count: 40

Registration Number: NCT01002898

Locations: 🇹🇭
Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand

Durability of Nevirapine-Based Antiretroviral Regimen

Phase 4

Completed

Conditions: HIV Infections

First Posted Date: 2008-06-24

Last Posted Date: 2008-07-08

Lead Sponsor: Bamrasnaradura Infectious Diseases Institute

Target Recruit Count: 140

Registration Number: NCT00703898

Locations: 🇹🇭
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Phase 3

Completed

Conditions: HIV Infections
Tuberculosis

Interventions: Drug: efavirenz
Drug: nevirapine

First Posted Date: 2007-06-06

Last Posted Date: 2011-11-22

Lead Sponsor: Bamrasnaradura Infectious Diseases Institute

Target Recruit Count: 142

Registration Number: NCT00483054

Locations: 🇹🇭
Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand

Nevirapine Levels and Fluconazole

Completed

Conditions: Nevirapine
Fluconazole
Adverse Event

First Posted Date: 2006-04-03

Last Posted Date: 2006-04-03

Lead Sponsor: Bamrasnaradura Infectious Diseases Institute

Registration Number: NCT00309582

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy